Charles River Laboratories vs IQVIA
Charles River Laboratories (CRL) and IQVIA (IQV) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $16.2B
- Last close
- $337.97
- 12 months
- +99.7%
- Market value
- $43.7B
- Last close
- $265.12
- 12 months
- +18.6%
At a glance
- By market value, IQVIA ($43.7B) is about 2.7 times Charles River Laboratories ($16.2B).
- Over the last 12 months Charles River Laboratories's share price moved +99.7% and IQVIA's +18.6%; against the S&P 500 that is +87.5 points and +6.3 points.
- In their last fiscal years Charles River Laboratories kept -3.6% of revenue as net income and IQVIA 8.3%.
- In the last 90 days insiders reported 0 open-market purchases at Charles River Laboratories and 0 at IQVIA; members of Congress disclosed 0 trades in Charles River Laboratories and 3 in IQVIA.
- Next results: Charles River Laboratories Feb 16, 2027, IQVIA Feb 3, 2027.
Share price over the last 12 months
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Charles River Laboratories CRLNYSE · Life Sciences Tools & Services | IQVIA IQVNYSE · Life Sciences Tools & Services | |
|---|---|---|
| Size and profitability | ||
| Market value | $16.2B | $43.7B |
| Revenue, last fiscal year | $4.02B | $16.3B |
| Net income, last fiscal year | −$144M | $1.36B |
| Net marginNet income as a share of revenue | -3.6% | 8.3% |
| Free cash flow | $518M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Charles River Laboratories against
Common questions
How do Charles River Laboratories and IQVIA compare in size?
IQVIA has the larger market value: Charles River Laboratories $16.2B and IQVIA $43.7B, at the last close.
Whose share price rose more over the last 12 months, CRL or IQV?
Over the last 12 months Charles River Laboratories moved +99.7% and IQVIA +18.6%. Past price moves say nothing about the future.
Which has had more insider buying, Charles River Laboratories or IQVIA?
Since 2006, Charles River Laboratories insiders reported 16 open-market purchases against 7 for IQVIA. These are counts of what was filed, not a view on either stock.
Do members of Congress trade CRL or IQV?
In the last 12 months, members of Congress disclosed 0 trades in Charles River Laboratories (CRL) and 6 in IQVIA (IQV).
When did insiders last buy CRL and IQV?
Charles River Laboratories: Mar 4, 2026. IQVIA: Feb 8, 2025.
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Charles River Laboratories pageIQVIA pageRare insider trades this weekAll comparisons
https://oqro.io/compare/crl-vs-iqv
